Capital Inc. Bdc Net Worth

The estimated Net Worth of Capital Inc. Bdc is at least $3.46 Milhão dollars as of 8 May 2019. Capital Bdc owns over 200,000 units of Milestone Pharmaceuticals Inc stock worth over $3,462,728 and over the last 6 years Capital sold MIST stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Capital Bdc MIST stock SEC Form 4 insiders trading

Capital has made over 1 trades of the Milestone Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Capital bought 200,000 units of MIST stock worth $3,000,000 on 8 May 2019.

The largest trade Capital's ever made was buying 200,000 units of Milestone Pharmaceuticals Inc stock on 8 May 2019 worth over $3,000,000. On average, Capital trades about 200,000 units every 0 days since 2019. As of 8 May 2019 Capital still owns at least 2,388,088 units of Milestone Pharmaceuticals Inc stock.

You can see the complete history of Capital Bdc stock trades at the bottom of the page.

What's Capital Bdc's mailing address?

Capital's mailing address filed with the SEC is SUITE 400, PLACE VILLE MARIE, , MONTREAL, A8, H3B 5E7.

Insiders trading at Milestone Pharmaceuticals Inc

Over the last 6 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic..., eJoseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.

What does Milestone Pharmaceuticals Inc do?

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Complete history of Capital Bdc stock trades at Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc executives and stock owners

Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Joseph G. Oliveto,
  CEO, Pres & Director
• Amit Hasija,
  CFO & Exec. VP of Corp. Devel.
• Dr. Francis Plat,
  Chief Medical Officer
• Lorenz Muller,
  Chief Commercial Officer
• Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Jeff Nelson,
  Chief Operating Officer
• Dr. Philippe Douville,
  Founder, Strategic Advisor & Member of Scientific Advisory Board
• Richard C Pasternak,
  Director
• Debra K. Liebert,
  Director
• Paul F Truex,
  Director
• Joseph C Papa,
  
• Amit Hasija,
  CFO & EVP of Corp. Development
• Seth H. Z. Fischer,
  
• Timothy Maness,
  Chief Accounting Officer
• Philippe Douville,
  Chief Scientific Officer
• De Solidarite Des Travaille...,
  10% owner
• Holdings A/S Novo,
  10% owner
• Investments, Lpwong Roderic...,
  
• Capital Inc. Bdc,
  10% owner
• Francis Plat,
  Chief Medical Officer
• Joseph Oliveto,
  President and CEO
• Lorenz Muller,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Michael John Tomsicek,
  
• Stuart Duty,
  
• David Bharucha,
  Chief Medical Officer
• Jeffrey Edward Nelson,
  Chief Operating Officer
• Lisa M. Giles,
  
• Robert James Wills,